4//SEC Filing
Mottola Frank 4
Accession 0001628280-25-011325
CIK 0001356576other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:34 PM ET
Size
8.7 KB
Accession
0001628280-25-011325
Insider Transaction Report
Form 4
Mottola Frank
SVP, Quality, GMP, Ops, IT
Transactions
- Exercise/Conversion
Common Stock
2025-03-07+2,625→ 16,507 total - Tax Payment
Common Stock
2025-03-07$39.11/sh−1,356$53,033→ 15,151 total - Exercise/Conversion
Performance Share Units
2025-03-07−2,625→ 0 totalExercise: $0.00→ Common Stock (2,625 underlying)
Footnotes (3)
- [F1]Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 17, 2025.
- [F2]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
- [F3]On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001804567
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:34 PM ET
- Size
- 8.7 KB